MRNA241206C51000
- 0.16
- +0.08+100.00%
Moderna Newsroom
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
Why Is Moderna, Inc. (MRNA) Among the Best High Growth Healthcare Stocks to Invest In Now?
December Starts With a Mixed Market | Live Stock
Moderna, Inc. (MRNA): A Bull Case Theory
US MOVERS&SHAKERS Nov 25-Nov 29, 2024
Moderna Options Spot-On: On November 27th, 118.24K Contracts Were Traded, With 656.81K Open Interest
Wednesday Ends With Index Decline | Wall Street Today
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Which Is a Better Buy: Moderna or Pfizer?
Moderna Price Target Lowered to $45 From $59 at JPMorgan
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
Moderna Options Spot-On: On November 26th, 73,882 Contracts Were Traded, With 646.06K Open Interest
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Bird Flu Found In Raw Milk Leads To Recall In California
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
Moderna Analyst Ratings
Moderna, Inc. (MRNA): An Oversold Healthcare Stock to Invest In Now
Moderna's Shares Surge Amid Promising Vaccine Developments and Strategic Partnerships
JPMorgan Adjusts Price Target on Moderna to $45 From $59, Maintains Underweight Rating